Annexin Pharmaceuticals AB
ANNX | FN
Overview
Corporate Details
- ISIN(s):
- SE0009664154
- LEI:
- 5493000JP703HGPJEX27
- Country:
- Sweden
- Address:
- KAMMAKARGATAN 48, 111 60 Stockholm
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Annexin Pharmaceuticals AB is a Swedish biotech company focused on therapies for cardiovascular and inflammatory diseases. Its pipeline is based on Annexin A5 protein.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH | |
|
IntegraGen | France | ALINT |